Positions

Overview

  • I joined the Faculty at UAB in 1981 after being a Research Fellow for about 18 months. I am currently Emeritus Professor and although not in Birmingham, I am still involved in mentoring fellows and collaborating with the LFA, LCTC, GLADEL as the need arises. During my stay at UAB and prior to that at my alma mater (Universidad Peruana Cayetano Heredia in Lima, Perú), I have been involved in the training of clinical and research fellows. In fact, after my US training (1968-1972), I started the first training program in Rheumatology and the first Rheumatology Unit in Perú. Whether in Perú or in the US, I have attended their clinics, have rounded with them, and foremost I have been stimulating them to always keep an open and inquisitive mind in dealing with their day-to-day activities being those in the clinic or in the research setting. I can say that over 60% of the fellows graduating from UAB between 1981 and the early 2000's, when I became more involved in the training of clinical research fellows (vide infra), have had the opportunity to publish their clinical experience under my mentorship and with my unconditional support. Of course, not all of them have become academicians or researchers in their own right, but I have been quick to point out to all of them that the proper appreciation of what research entails or the amount of work that goes into a published paper, can only come from personally going through the same experience.

    Although I have been involved in mentoring Junior Faculty and clinical research fellows in the past, it has been only since 2002 that I have had the opportunity to LUMINAcollaboratorshave the funding to support them for the conduct of research in lupus. These fellows have used the very rich database from LUMINA, a multi-ethnic cohort of lupus patients established in collaboration with Drs. John Reveille (UT-Houston, TX) and Luis Vilá (U- Puerto Rico, San Juan, PR) in the early 1990's. Participating in the training of these young physicians while continuing to mentor Junior Faculty and clinical fellows, as time permits, has been, and continues to be, one of the most rewording but also challenging experiences of my academic life as a rheumatologist. For the most part, these trainees have come with limited research experience; despite that, they have performed spectacularly well. In addition to participating in data collection on patients from the cohort, they have generated their own sub-projects and taken them to completion including the Gladel 2publication of their findings in prestigious rheumatology journals. The fruits of LUMINA have been summarized in a special article published in the Journal Lupus in 2008. Moreover, the salient finding from the LUMINA study were highlighted in an article published in The Rheumatologist in the Spring of 2011. At the present time, I continue to be involved in the work of the fellows that trained with me over the last few years (Drs. Durán-Barragán, González, Pons-Estel and Burgos) who are conducting research in lupus in their country of origin. In parallel I am assisting the LCTC in the establishment of a national registry of lupus patients (US and Canada). Finally, over the last few years I have developed a very close relationship with GLADEL (for Grupo Latinoamericano de Estudio de Lupus or Latin American Group for the Study of Lupus), assisting them in the utilization of their rich database. This group with the support of PANLAR is now developing the Latin American treatment guidelines for lupus, effort in which I am quite involved.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Evaluating the Properties of a Frailty Index and Its Association With Mortality Risk Among Patients With Systemic Lupus Erythematosus 2019
    2019 Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort 2019
    2019 Jaccoud's arthropathy in SLE: Findings from a Latin American multiethnic population 2019
    2019 Lupus: the new epidemic 2019
    2019 Antinuclear Antibody–Negative Systemic Lupus Erythematosus in an International Inception Cohort 2019
    2019 Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort 2019
    2019 Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen 2019
    2019 Correction to: Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort (Clinical Rheumatology, (2019), 38, 4, (1139-1146), 10.1007/s10067-018-4389-3) 2019
    2019 Medical Scientific Publications From Latin America: A Commentary 2019
    2019 Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial 2019
    2019 Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: Results from LUMINA (LXXIX), a multiethnic, multicentre US cohort 2019
    2019 Homocysteine levels are independently associated with damage accrual in systemic lupus erythematosus patients from a Latin-American cohort 2019
    2019 Erratum corrige: "Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients". M.F. Ugarte-Gil et al 2019
    2019 Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort 2019
    2019 Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study 2019
    2019 Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort 2019
    2019 Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort (Clinical Rheumatology, (2019), 10.1007/s10067-019-04618-x) 2019
    2019 Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort 2019
    2019 Overrepresentation of elderly subjects in a population-based study of antiphospholipid syndrome: comment on the article by Duarte-García et al 2019
    2019 Remission or low disease activity as a target in systemic lupus erythematosus 2019
    2018 Is Low Disease Activity Sufficient as a Target in Systemic Lupus Erythematosus? Comment on the Article by Petri et al 2018
    2018 Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions 2018
    2018 First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR) 2018
    2018 Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients 2018
    2018 Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study 2018
    2018 A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients 2018
    2018 Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach 2018
    2018 Rheumatoid arthritis in the indigenous qom population of Rosario, Argentina: aggressive and disabling disease with inadequate adherence to treatment in a community-based cohort study 2018
    2018 A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus 2018
    2018 Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort 2018
    2018 Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort 2018
    2018 Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans 2018
    2018 Response to: 'Clinical evidence guidelines in systemic lupus erythematosus: Revaluation' by Scheinberg 2018
    2018 Sex Differences in Quality of Life in Patients With Systemic Lupus Erythematosus 2018
    2018 Therapeutic Guidelines for Latin American Lupus Patients: Methodology 2018
    2017 Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL) 2017
    2017 Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL) 2017
    2017 Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort 2017
    2017 The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients 2017
    2017 Epidemiology of systemic lupus erythematosus 2017
    2017 The evolving concept of SLE comorbidities 2017
    2017 Transancestral mapping and genetic load in systemic lupus erythematosus 2017
    2017 Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus 2017
    2017 A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients 2017
    2017 Factors associated with disease expression patterns in systemic lupus erythematosus patients: Results from LUMINA (LXXVII), a multiethnic US cohort 2017
    2017 Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients 2017
    2017 Defining quality of rheumatologic care: Peru 2017
    2017 The caregiver burden in lupus: Findings from UNVEIL, a national online lupus survey in the United States 2017
    2016 Systemic Lupus Erythematosus: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data 2016
    2016 Vasculitis as an adverse event following immunization – Systematic literature review 2016
    2016 Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context 2016
    2016 Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production 2016
    2016 Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients 2016
    2016 The Evelyn Hess Memorial Lecture 2016
    2016 Treatment Algorithms for Patients with Systemic Lupus Erythematosus: Comment on the Article by Muangchan et al 2016
    2016 A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach 2016
    2016 Treat to target in systemic lupus erythematosus: a commentary 2016
    2016 Features associated with hematologic abnormalities and their impact in patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort 2016
    2016 X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome 2016
    2016 Abatacept for the treatment of systemic lupus erythematosus 2016
    2016 Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients 2016
    2016 Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary 2016
    2016 Incomplete Systemic Lupus Erythematosus: Early Diagnosis or Overdiagnosis? 2016
    2016 The frequency and outcome of lupus nephritis: results from an international inception cohort study 2016
    2016 Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort 2016
    2016 Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA 2016
    2015 Associations of Non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci 2015
    2015 Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus 2015
    2015 Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort 2015
    2015 Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort 2015
    2015 Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort 2015
    2015 Circulating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: Data from a primarily Mestizo population 2015
    2015 Lupus in Latin-American patients: Lessons from the GLADEL cohort 2015
    2015 Anti-C1q antibodies in systemic lupus erythematosus 2015
    2015 Electrocardiographic findings in systemic lupus erythematosus: Data from an international inception cohort 2015
    2015 Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study 2015
    2015 Late-onset systemic lupus erythematosus in Latin Americans: A distinct subgroup? 2015
    2015 Lupus risk variant increases pSTAT1 binding and decreases ETS1 expression 2015
    2015 Mood disorders in systemic lupus erythematosus: Results from an international inception cohort study 2015
    2015 Racial and Ethnic Differences in Mortality and Cardiovascular Events among Patients with End-Stage Renal Disease Due to Lupus Nephritis 2015
    2015 Racial/ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: A Hispanic and asian paradox 2015
    2015 The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share 2015
    2014 Factors associated with damage accrual in patients with systemic lupus erythematosus: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort 2014
    2014 Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort 2014
    2014 The panlar rheumatology prize for latin american rheumatologists: An incentive for rheumatologists entering the field: A 5-year report 2014
    2014 The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: Data from a multiethnic Latin American cohort 2014
    2014 American college of rheumatology criteria at inception, and accrual over 5 years in the slicc inception cohort 2014
    2014 Brief report: A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus 2014
    2014 Changes in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosus 2014
    2014 Development and validation of the lupus impact tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus 2014
    2014 Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: Data from LUMINA (LXXVI), a multi-ethnic us cohort 2014
    2014 End-stage renal disease in African Americans with lupus nephritis is associated with APOL1 2014
    2014 Erratum: Incorrect values for intractable and cluster headaches at enrollment shown in figure 1 and incorrect prevalence of headache at ten years in text of the article by hanly et al (Arthritis and Rheumatology (2013)) 2014
    2014 Fcγ receptor IIIa single-nucleotide polymorphisms and haplotypes affect human IgG binding and are associated with lupus nephritis in African Americans 2014
    2014 High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients 2014
    2014 Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus 2014
    2014 Lupus risk variants in the PXK locus alter B-cell receptor internalization 2014
    2014 Primary cardiac disease in systemic lupus erythematosus patients: Protective and risk factors-data from a multi-ethnic Latin American cohort 2014
    2014 Systemic lupus erythematosus: A therapeutic challenge for the XXI century 2014
    2014 The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics Classification criteria for systemic lupus erythematosus in two multiethnic cohorts: A commentary 2014
    2013 Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses 2013
    2013 Erythropoiesis-stimulating Agent Use among Patients with Lupus Nephritis Approaching End-stage Renal Disease. 2013
    2013 Value of isolated IgA anti-β2-glycoprotein i positivity in the diagnosis of the antiphospholipid syndrome 2013
    2013 ABIN1 dysfunction as a genetic basis for lupus nephritis 2013
    2013 Headache in systemic lupus erythematosus: Results from a prospective, international inception cohort study 2013
    2013 Non-lymphoma hematological malignancies in systemic lupus erythematosus 2013
    2013 Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression 2013
    2013 PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes 2013
    2013 Clinical associations of the metabolic syndrome in systemic lupus erythematosus: Data from an international inception cohort 2013
    2013 Is there an effective treatment for late-onset systemic lupus erythematosus? 2013
    2013 Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry 2013
    2013 Cancer risk in systemic lupus: An updated international multi-centre cohort study 2013
    2013 Spanish LupusPRO: Cross-cultural validation study for lupus 2013
    2013 Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004 2013
    2013 Fine mapping of Xq28: Both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups 2013
    2013 Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production 2013
    2013 Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes. 2013
    2013 Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: Data from a Latin American cohort 2013
    2013 MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus 2013
    2013 Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians 2013
    2012 Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus 2012
    2012 Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations 2012
    2012 The impact of rural residency on the expression and outcome of systemic lupus erythematosus: Data from a multiethnic Latin American cohort 2012
    2012 Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries 2012
    2012 Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study 2012
    2012 Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus 2012
    2012 Genetic risk factors for thrombosis in systemic lupus erythematosus 2012
    2012 Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary population 2012
    2012 A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus 2012
    2012 Anti-malarials exert a protective effect while mestizo patients are at increased risk of developing SLE renal disease: Data from a Latin-American cohort 2012
    2012 Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: Data from LUMINA (LXXV), a multiethnic US cohort 2012
    2012 Evaluation of TRAF6 in a large multiancestral lupus cohort 2012
    2012 Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus 2012
    2012 Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort. 2012
    2012 Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study 2012
    2012 Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis 2012
    2012 IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus 2012
    2012 Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus 2012
    2012 Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort 2012
    2012 Lupus in hispanics: A matter of serious concern 2012
    2011 Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States 2011
    2011 Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study 2011
    2011 Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus 2011
    2011 Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus 2011
    2011 Decreased live births in women with systemic lupus erythematosus 2011
    2011 Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus 2011
    2011 Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21 2011
    2011 SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus 2011
    2011 Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006 2011
    2011 Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility 2011
    2011 Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. 2011
    2011 International consensus for a definition of disease flare in lupus 2011
    2011 Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity 2011
    2011 US patients of hispanic and African ancestry develop lupus nephritis early in the disease course: Data from LUMINA, a multiethnic US cohort (LUMINA LXXIV) 2011
    2011 An assessment of disease flare in patients with systemic lupus erythematosus: A comparison of BILAG 2004 and the flare version of SELENA 2011
    2011 End-stage renal disease due to lupus nephritis among children in the US, 1995-2006 2011
    2011 Multiethnic lupus cohorts: What have they taught us? 2011
    2010 Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort 2010
    2010 The role of genetic variation near interferon-kappa in systemic lupus erythematosus 2010
    2010 Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis 2010
    2010 Perspectives on the management of late-onset systemic lupus erythematosus 2010
    2010 Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: Cross-cultural issues 2010
    2010 ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry 2010
    2010 The non-muscle myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans 2010
    2010 Preventive health services for systemic lupus erythematosus patients: Whose job is it? 2010
    2010 Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus 2010
    2010 Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII) 2010
    2010 Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis 2010
    2010 Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX 2010
    2010 Radiographic severity of rheumatoid arthritis in African Americans: Results from a multicenter observational study 2010
    2010 Development and initial validation of a self-assessed lupus organ damage instrument 2010
    2010 Genetic variants of STAT4 associated with rheumatoid arthritis in persons of Asian and European ancestry do not replicate in African Americans 2010
    2010 Reply 2010
    2010 Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort 2010
    2010 Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus 2010
    2010 Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus 2010
    2010 Vitamin D status and its associations with disease activity and severity in african americans with recent-onset rheumatoid arthritis 2010
    2010 Value of assessing the fifth metatarsophalangeal joint in patients with early rheumatoid arthritis: Comment on the article by Sheane et al 2010
    2010 Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort 2010
    2010 Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19) 2010
    2009 Risk factors for thrombotic events in patients with systemic lupus erythematosus from different 2009
    2009 Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX). 2009
    2009 Thrombosis in systemic lupus erythematosus: Risk and protection 2009
    2009 Reply 2009
    2009 A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus 2009
    2009 Skeletal health among African Americans with recent-onset rheumatoid arthritis 2009
    2009 Factors associated with arterial vascular events in PROFILE: A multiethnic lupus cohort 2009
    2009 Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: Data from North and South America, Spain and Portugal 2009
    2009 Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII 2009
    2009 Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27) 2009
    2009 Questioning the likelihood that sodium oxybate can be used to successfully treat fibromyalgia: Comment on the article by Russell et al 2009
    2009 Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: Data from a single US institution 2009
    2009 A polymorphism within IL21R confers risk for systemic lupus erythematosus 2009
    2009 Time to neuropsychiatric damage occurrence in LUMINA (LXVI): A multi-ethnic lupus cohort 2009
    2009 Predictors of cardiovascular damage in patients with systemic lupus erythematosus: Data from LUMINA (LXVIII), a multiethnic US cohort 2009
    2009 Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort 2009
    2009 Renal damage is the most important predictor of mortality within the damage index: Data from LUMINA LXIV, a multiethnic US cohort 2009
    2009 Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population 2009
    2009 Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus 2009
    2009 An african ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in african americans 2009
    2009 Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII) 2009
    2009 Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing 2009
    2009 Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus form the LUMINA cohort (LXII): Use of the SF-6D 2009
    2009 Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. 2009
    2009 Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity 2009
    2009 Genetic associations of LYN with systemic lupus erythematosus 2009
    2009 Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico. 2009
    2009 Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis 2009
    2009 Retraction: an African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. 2009
    2008 Lessons from LUMINA: A multiethnic US cohort 2008
    2008 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage 2008
    2008 Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis 2008
    2008 Employment and disability issues in systemic lupus erythematosus: A review 2008
    2008 Methotrexate is not associated with progression of interstitial lung disease in rheumatoid arthritis 2008
    2008 Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort 2008
    2008 Ultrasound of target joints for the evaluation of possible inflammatory arthropathy: Associated clinical factors and diagnostic accuracy 2008
    2008 Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene-dose effect from the X chromosome 2008
    2008 Late-onset lupus: Facts and fiction 2008
    2008 Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII) 2008
    2008 Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus - Results from LUMINA (LIX): A multiethnic US cohort 2008
    2008 Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context 2008
    2008 Seizures in patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA LIV) 2008
    2008 Systemic lupus international collaborating clinics renal activity/response exercise: Comparison of agreement in rating renal response 2008
    2008 Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index 2008
    2008 Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII) 2008
    2008 Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study 2008
    2008 Erratum: Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) (Clinical and Experimental Rheumatology (2008) vol. 26 (268-274)) 2008
    2008 Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort 2008
    2008 Genetic variation in the CRP promoter: Association with systemic lupus erythematosus 2008
    2008 Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans 2008
    2008 Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: Disease expression and outcome in acute onset lupus 2008
    2008 Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LUI) 2008
    2008 Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: Results from an international inception cohort study 2008
    2008 Accumulation of coronary artery disease risk factors over three years: Data from an international inception cohort 2008
    2008 IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 2008
    2008 The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture 2008
    2008 Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort 2008
    2008 Systemic lupus erythematosus in a multiethnic us cohort, lumina (xlix): Preliminary evaluation of the impact of statins on disease activity 2008
    2008 The relationship between cancer and medication exposures in systemic lupus erythaematosus: A case-cohort study 2008
    2007 Measurement of fatigue in systemic lupus erythematosus: A systematic review 2007
    2007 Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus erythematosus: Lessons from LUMINA, a multiethnic US cohort 2007
    2007 Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort 2007
    2007 Does medical insurance matter in the progression to endstage renal disease among patients with lupus nephritis? 2007
    2007 Erratum: The impact of increased body mass index on systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA XLVI) (Journal of Clinical Rheumatology (2007) 3, (128-133)) 2007
    2007 Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups 2007
    2007 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): Relationship between vascular events and the use of hormone replacement therapy in postmenopausal women 2007
    2007 Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects 2007
    2007 Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (LUMINA L) 2007
    2007 Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: Anaemia as a predictor of disease activity and damage accrual 2007
    2007 Using the short form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort 2007
    2007 Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials 2007
    2007 Pulmonary manifestations of rheumatoid arthritis 2007
    2007 Reply [4] 2007
    2007 Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: Factors predictive of pulmonary damage 2007
    2007 Systemic lupus erythematosus and ethnicity: Nature versus nurture or nature and nurture? 2007
    2007 The heart-joints connection: Atherosclerosis and inflammation 2007
    2007 The impact of increased body mass index on systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort 2007
    2007 A multiethnic, multicenter cohort of patients with Systemic Lupus Erythematosus (SLE) as a model for the study of ethnic disparities in SLE 2007
    2007 African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: Results from LUMINA, a multiethnic cohort (LUMINAXLV) 2007
    2007 Effect of reproductive factors on rheumatoid arthritis 2007
    2007 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: Factors predictive of new or worsening proteinuria 2007
    2007 Accelerated damage accrual among men with systemic lupus erythematosus XLIV. Results from a multiethnic US cohort 2007
    2007 C-reactive protein polymorphism and Crohn's disease [1] 2007
    2007 Systemic lupus erythematosus in a multiethnic US cohort XLIII. The significance of thrombocytopenia as a prognostic factor 2007
    2007 Ultrasound detects rapid progression of erosive disease in early rheumatoid arthritis: A prospective longitudinal study 2007
    2007 Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study 2007
    2007 Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): Factors predictive of self-reported work disability 2007
    2006 Infections in Systemic Connective Tissue Diseases: Systemic Lupus Erythematosus, Scleroderma, and Polymyositis/Dermatomyositis 2006
    2006 Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL) [3] 2006
    2006 Systemic lupus erythematosus in a multiethnic cohort (LUMINAXXXIX): Relationship between hormone replacement therapy and disease activity over time [2] 2006
    2006 Does caffeine intake affect methotrexate efficacy?: Commentary 2006
    2006 Predictors of post-partum damage accrual in systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (XXXVIII) 2006
    2006 Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: Association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual 2006
    2006 Time to renal disease and end-stage renal disease in PROFILE: A multiethnic lupus cohort 2006
    2006 Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis 2006
    2006 Racial or ethnic differences in allele frequencies of sinqle-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis 2006
    2006 Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time 2006
    2006 Clinical research: A primer of practical tips [1] 2006
    2006 Mortality in systemic lupus erythematosus 2006
    2006 Erratum: Systemic Lupus Erythematosus in a Multi-ethnic Cohort (LUMINA) XXXII: Contributions of admixture and socioeconomic status to renal involvement (Lupus (2006) 15 (26-31)) 2006
    2006 Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: Comment on the article by Frostegård et al [6] 2006
    2006 Early rheumatoid arthritis: Combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy: Commentary 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: Results of a nested matched case-control study 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events 2006
    2006 Does obesity play a role in functional capacity and inflammation in patients with lupus? Comment on the article by Oeser et al. [1] 2006
    2006 Effect of folic acid supplementation on the efficacy of metholrexate treatment in rheumatoid arthritis: Comment on the article by Khaanna et al. [5] 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome 2006
    2006 Ozone therapy and lower back pain [1] 2006
    2006 Cyclophosphamide use and pregnancy in lupus [3] 2006
    2006 Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA): Contributions of admixture and socioeconomic status to renal involvement 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: Factors predictive of a decline to low levels of disease activity 2006
    2006 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: Factors associated with patients being lost to follow-up 2006
    2006 Ultrasound appearance of knuckle pads. 2006
    2005 Ethnic disparities in health and disease: The need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI) [1] 2005
    2005 Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual 2005
    2005 Race/ethnicity and cancer occurrence in systemic lupus erythematosus 2005
    2005 Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events 2005
    2005 Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients 2005
    2005 Prevalence of osteoporosis and osteopenia among African Americans with early rheumatoid arthritis: The impact of ethnic-specific normative data 2005
    2005 Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: Association between C-reactive protein (CRP) gene polymorphisms and vascular events 2005
    2005 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients 2005
    2005 The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial 2005
    2005 Pain-related beliefs and affective pain responses: Implications for ethnic disparities in preferences for joint arthroplasty 2005
    2005 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women 2005
    2005 An international cohort study of cancer in systemic lupus erythematosus 2005
    2005 Effect of ethnicity on disease activity in systemic lupus erythematosus [1] (multiple letters) 2005
    2005 Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual 2005
    2005 Classification of the vasculitides: are they clinically useful? 2005
    2004 Lessons from fibromyalgia: Abnormal pain sensitivity in knee osteoarthritis 2004
    2004 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events 2004
    2004 The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity 2004
    2004 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage 2004
    2004 The Systemic Lupus Activity Measure-Revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a Modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus 2004
    2004 The effect of folic acid and folinic acid supplements on purine metabolism in methotrexate-treated rheumatoid arthritis 2004
    2004 Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: Data from the LUMINA cohort 2004
    2004 Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis 2004
    2004 Monitoring guidelines for methotrexate-treated rheumatoid arthritis patients: Comment on the article by Yazici et al [1] (multiple letters) 2004
    2004 Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course 2004
    2004 What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? 2004
    2004 Systemic Lupus Erythematosus in Three Ethnic Groups. XVIII. Factors Predictive of Poor Compliance with Study Visits 2004
    2004 Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations 2004
    2004 Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres 2004
    2004 Systemic lupus erythematosus and gouty arthritis: An uncommon association 2004
    2004 Systemic Lupus Erythematosus in Three Ethnic Groups. XIV. Poverty, Wealth, and Their Influence on Disease Activity 2004
    2004 Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage 2004
    2004 Ultrasound detection of bone erosions in rheumatoid arthritis: A comparison to routine radiographs of the hands and feet 2004
    2003 A 2-Phase Screening Process for Patients with Wegener's Granulomatosis: A Pilot Study 2003
    2003 Early rheumatoid arthritis in African-Americans: The CLEAR registry 2003
    2003 Early rheumatoid arthritis in African-Americans: the CLEAR Registry. 2003
    2003 Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology Criteria 2003
    2003 Clinical, immunogenetic and outcome features of hispanic systemic lupus erythematosus patients of different ethnic ancestry 2003
    2003 Systemic lupus erythematosus in three ethnic groups: XV prevalence and correlates of fibromyalgia 2003
    2003 Dosage of hydroxychloroquine should be based on ideal body weight: Comment on the letter by Alarcón [8] (multiple letters) 2003
    2003 Infections in systemic connective tissue diseases: Systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis 2003
    2003 The managed care versus fee for service dilemma and its impact on the outcome of lupus 2003
    2003 Ethnic disparities in patients with systemic lupus erythematosus. 2003
    2003 Juvenile dermatomyositis in a 28-month-old infant 2003
    2002 A reply to comments on sociocultural issues in clinical research: Unraveling the Tuskegee Syphilis Study [1] 2002
    2002 Normal radiographs in patients with persistent "hip pain" - Value of magnetic resonance imaging 2002
    2002 Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores 2002
    2002 High-resolution ultrasound for the study of target joints in rheumatoid arthritis [1] (multiple letters) 2002
    2002 Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory 2002
    2002 Baseline characteristics of a multiethnic lupus cohort: PROFILE 2002
    2002 Erratum: Baseline characteristics of a multiethnic lupus cohort: PROFILE (Lupus (2002) 11 (95)) 2002
    2002 Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: Comment on the article by van Ede et al [6] 2002
    2002 How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy? [4] 2002
    2002 Is fibromyalgia a neurologic disease? 2002
    2002 Is it fibromyalgia? Is it lupus? Too much or not enough: Comments related to women referred to a tertiary care academic rheumatology research and treatment center 2002
    2002 Is it fibromyalgia? Is it lupus? Too much or not enough: Comments related to women referred to a tertiary care academic rheumatology research and treatment center 2002
    2002 SLE in three ethnic groups XIII. The 'weighted' criteria as predictors of damage 2002
    2002 Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis 2002
    2001 Methotrexate in giant-cell arteritis [2] (multiple letters) 2001
    2001 Protein-losing enteropathy in a young African-American woman with abdominal pain, diarrhea and hydronephrosis 2001
    2001 Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. 2001
    2001 Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrual 2001
    2001 Of ethnicity, race and lupus 2001
    2001 Sociocultural issues in clinical research 2001
    2001 Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort 2001
    2001 Psychosocial and health status variables independently predict health care seeking in fibromyalgia 2001
    2001 MTX affects inflammation and tissue destruction differently in the rat AA model 2001
    2001 Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestations 2001
    2001 Low-binding alleles of fcγ receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in hispanic patients 2001
    2001 Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus 2001
    2001 Hip pain as the presenting manifestation of acute gouty sacroiliitis 2001
    2001 Preface 2001
    2001 Psoriatic arthritis, methotrexate, and liver toxicity 2001
    2001 Women in rheumatology [1] 2001
    2000 The impact of women in the practice of academic and clinical rheumatology in the Americas 2000
    2000 Renal failure: A risk factor for methotrexate toxicity 2000
    2000 Renal failure: a risk factor for methotrexate toxicity. 2000
    2000 Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline 2000
    2000 Folic acid supplementation and methotrexate efficacy: Comment on articles by Schiff, Emery et al, and others [3] 2000
    2000 Methotrexate use in rheumatoid arthritis. A clinician's perspective 2000
    2000 Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. 2000
    2000 Preface 2000
    2000 Response to methotrexate and reduced mortality in patients with rheumatoid arthritis: Comment on the article by Krause et al [2] (multiple letters) 2000
    2000 Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis 2000
    2000 Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. 2000
    2000 Tetracyclines for the treatment of rheumatoid arthritis 2000
    2000 Unclassified or undifferentiated connective tissue disease 2000
    2000 Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. 2000
    1999 Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia? [1] 1999
    1999 Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug [1] (multiple letters) 1999
    1999 Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials 1999
    1999 Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study 1999
    1999 Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in hispanic patients from the LUMINA cohort 1999
    1999 Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis 1999
    1999 Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and undifferentiated CTD 1999
    1999 Fibromyalgia and physical and emotional trauma: How are they related? Comment on the article by Aaron et al [5] (multiple letters) 1999
    1999 Antibiotics for rheumatoid arthritis? Minocycline shows promise in some patients. 1999
    1999 The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes 1999
    1999 The influence of sex on the frequency of erosive disease and extraarticular manifestations in rheumatoid arthritis: Comment on the article by Weyand et al [3] 1999
    1999 Self-administered joint counts in rheumatoid arthritis: Comparison with standard joint counts 1999
    1999 Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug 1999
    1999 Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort 1999
    1999 Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. 1999
    1998 Folic acid supplementation prevents deficient blood [1] (multiple letters) 1998
    1998 Clinical Features of ANA Positive and ANA-Negative Patients with Fibromyalgia. 1998
    1998 Intravenous methotrexate in the treatment of resistant chronic polyarthritis. 1998
    1998 Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue 1998
    1998 Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset 1998
    1998 Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course 1998
    1998 Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention 1998
    1998 Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: Disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases 1998
    1998 Abnormal functional activity of the central nervous system in fibromyalgia syndrome 1998
    1998 Advances in the treatment of fibromyalgia: Current status and future directions 1998
    1998 Clinical features of ANA-positive and ANA-negative patients with fibromyalgia 1998
    1998 Clinical features of ANA-positive and ANA-negative patients with fibromyalgia [3] (multiple letters) 1998
    1998 Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia 1998
    1998 Introduction: Fibromyalgia symposium 1998
    1998 Minocycline for the treatment of rheumatoid arthritis 1998
    1998 Response on the positive ANA in an asymptomatic young woman [2] 1998
    1998 Sexual and physical abuse in women with fibromyalgia: Association with outpatient health care utilization and pain medication usage 1998
    1998 Sexual and physical abuse in women with fibromyalgia: Association with outpatient health care utilization and pain medication usage 1998
    1997 Predictive factors in rheumatoid arthritis 1997
    1997 Predictive factors in rheumatoid arthritis. 1997
    1997 Abnormal pain perception in patients with fibromyalgia: comment on the article by Bendtsen et al. 1997
    1997 A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial 1997
    1997 Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: A multicenter study with literature review 1997
    1997 Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis: A multicenter, case-control study 1997
    1997 Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone. 1997
    1997 Arthralgias, myalgias, facial erythema, and a positive ANA: Not necessarily SLE 1997
    1997 Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) trial 1997
    1997 Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et al 1997
    1997 Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: Comment on the article by Pasero et al [3] 1997
    1997 Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial 1997
    1997 Perceived physical and emotional trauma as precipitating events in fibromyalgia: Associations with health care seeking and disability status but not pain severity 1997
    1997 Comment on transient osteoporosis of the HIP 1997
    1997 Guidelines for folate supplementation in rheumatoid arthritis patients treated with methotrexate: Comment on the guidelines for monitoring drug therapy [1] (multiple letters) 1997
    1997 Methotrexate in rheumatoid arthritis. Folate supplementation should always be given 1997
    1997 Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis 1997
    1997 Nutrient intake patterns, body mass index, and vitamin levels in patients with rheumatoid arthritis 1997
    1996 Another look at minocycline (multiple letters) 1996
    1996 Folinic acid to prevent side effects of methotrexate in juvenile rheumatoid arthritis [3] 1996
    1996 Coping strategies predict disability in patients with primary fibromyalgia 1996
    1996 HLA-DRB1 genes and disease severity in rheumatoid arthritis 1996
    1996 Reactive arthritis in patients attending an urban sexually transmitted diseases clinic 1996
    1996 Systemic lupus erythematosus: Predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: Multivariate analyses and identification of risk factors 1996
    1996 Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness 1996
    1996 Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: Followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline 1996
    1996 Folic acid and methotrexate in rheumatoid arthritis [2] 1996
    1996 Rheumatoid arthritis preceding the onset of polyarticular tophaceous gout. 1996
    1996 The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: Will we ever have consensus about its use? 1996
    1995 Most African-American patients with rheumatoid arthritis do not have the rheumatoid antigenic determinant (epitope) 1995
    1995 Rheumatology 1995
    1995 Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo- controlled trial 1995
    1995 Adverse events in methotrexate-treated rheumatoid arthritis patients 1995
    1995 Adverse events in methotrexate-treated rheumatoid arthritis patients 1995
    1995 Development of an observation method for assessing pain behaviors in children with juvenile rheumatoid arthritis 1995
    1995 Epidemiology of rheumatoid arthritis 1995
    1995 Fibromyalgia in women 1995
    1995 Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed up for systemic lupus erythematosus at a large tertiary care center 1995
    1995 Improved methotrexate patient information 1995
    1995 Minocycline in rheumatoid arthritis [2] 1995
    1995 Musculoskeletal syndromes associated with malignancies 1995
    1995 Predictors of renal involvement in patients with recent onset systemic lupus erythematosus 1995
    1995 Reply 1995
    1995 Stress fractures in rheumatoid arthritis: comment on the article by wei 1995
    1995 Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients 1995
    1995 Systemic disorders with rheumatic manifestations: Editorial overview 1995
    1995 Tetracyclines in the treatment of rheumatoid arthritis 1995
    1994 Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: A double-blind, placebo-controlled trial 1994
    1994 Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus 1994
    1994 Antimicrobials in the treatment of rheumatoid arthritis and other arthritides: A clinical perspective 1994
    1994 HIP Osteonecrosis Secondary to the Administration of Corticosteroids for Feigned Bronchial Asthma 1994
    1994 Health care seeking behavior in fibromyalgia: Associations with pain thresholds, symptom severity, and psychiatric morbidity 1994
    1994 Issues in meta‐analysis: An overview 1994
    1994 Methotrexate for Rheumatoid Arthritis 1994
    1994 Reply 1994
    1994 Survival impact of autoantibodies in systemic lupus erythematosus 1994
    1993 Functional magnetic resonance imaging should be included in the evaluation of the cervical spine in patients with rheumatoid arthritis 1993
    1993 Meta analysis of the effect of methotrexate on radiologic progression in rheumatoid arthritis [1] 1993
    1993 On women's issues. 1993
    1993 Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival 1993
    1993 Antifolates in rheumatoid arthritis: A hypothetical mechanism of action 1993
    1993 Comparison of naproxen and acetaminophen in a two‐year study of treatment of osteoarthritis of the knee 1993
    1993 Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis 1993
    1993 Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis) 1993
    1993 Folate supplementation and methotrexate [3] 1993
    1993 Folic acid supplementation during methotrexate therapy: It makes sense 1993
    1993 Insufficiency fracture of the distal ulna presenting as cellulitis 1993
    1993 MR imaging of the hands in early rheumatoid arthritis: preliminary results. 1993
    1993 Methotrexate and sulfasalazine combination therapy: Is it worth the risk? 1993
    1993 Nongonococcal bacterial arthritis 1993
    1993 Nonperipheral accelerated nodulosis in a methotrexate‐treated rheumatoid arthritis patient 1993
    1993 On women's lssues 1993
    1993 Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two 1993
    1993 Reply 1993
    1993 Selected surgical topics in rheumatoid arthritis 1993
    1993 Sternoclavicular brucellar arthritis: A report of 7 cases and a review of the literature 1993
    1993 Use of self ‐ administered joint counts in the evaluation of rheumatoid arthritis patients 1993
    1992 Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis 1992
    1992 Arthritis due to tuberculosis, fungal infections, and parasites 1992
    1992 Comparison of auranofin, methotreaxate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial 1992
    1992 Controlled trial of methotrexate versus 10-deazaaminopterin in the treatment of rheumatoid arthritis 1992
    1992 Digital subtraction radiography for the assessment of bone changes in rheumatoid arthritis 1992
    1992 Efficacy and safety of 10‐deazaaminopterin in the treatment of rheumatoid arthritis: A one‐year continuation, double‐blind study 1992
    1992 Letter to the editor [2] 1992
    1992 The early diagnosis of transient osteoporosis by magnetic resonance imaging. A case report 1992
    1991 A comparison of the full and short versions of the arthritis impact measurement scales 1991
    1991 A comparison of the full and short versions of the arthritis impact measurement scales 1991
    1991 Arthritis care and research. A quality/needs assessment 1991
    1991 Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists 1991
    1991 Combination of disease‐modifying antirheumatic drugs in the treatment of rheumatoid arthritis A survey of alabama rheumatologists 1991
    1991 Disease and psychosocial factors related to physical functioning in rheumatoid arthritis 1991
    1991 Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease 1991
    1991 Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases 1991
    1991 Insufficiency fractures of the distal tibia misdiagnosed as cellulitis in three patients with rheumatoid arthritis 1991
    1991 Prosthetic joint infections. A role for prophylaxis 1991
    1991 Rheumatoid arthritis patients and clinical drug trials A case‐control study 1991
    1991 Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? 1991
    1991 The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip 1991
    1991 Working for arthritis care and research. The editorial office and the AHPA membership 1991
    1990 Activated lymphocytes in peripheral blood of patients with RA 1990
    1990 Occurrence of a rheumatoid factor cross-reactive kappa light-chain idiotope in rheumatoid arthritis families 1990
    1990 Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation 1990
    1990 Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires 1990
    1990 5-Fluorouracil in the treatment of scleroderma: A randomised, double blind, placebo controlled international collaborative study 1990
    1990 A Curriculum in Clinical Sexuality for Arthritis Health Care Professionals 1990
    1990 Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with Methotrexate 1990
    1990 Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with methotrexate 1990
    1990 Comment on the article by calin et al 1990
    1990 Letter to the editor (I) 1990
    1990 Letter to the editor (I) 1990
    1990 Letters 1990
    1990 Misoprostol in treatment of gastropathy due to nonsteroidal anti-inflammatory drugs 1990
    1990 Mortality vs quality of life (I) 1990
    1990 Prognosis in systemic lupus erythematosus 1990
    1990 Rheumatology algorithms for primary care physicians 1990
    1990 Rheumatology algorithms for primary care physicians 1990
    1990 Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis: Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression 1990
    1990 The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand 1990
    1990 The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis 1990
    1990 The value of the Norgaard view in the evaluation of erosive arthritis 1990
    1990 Toxic response to topical fluorouracil in two rheumatoid arthritis patients receiving low‐dose, weekly methotrexate 1990
    1989 Discriminant and convergent validity of self-report measures of affective distress in patients with rheumatoid arthritis 1989
    1989 Thrombotic thrombocytopenic purpura in systemic sclerosis. 1989
    1989 Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. 1989
    1989 Bacterial infections 1989
    1989 Clinical characteristics affecting survival in patients with rheumatoid arthritis undergoing cervical spine surgery: A controlled study 1989
    1989 Comment on the article by Furst et al 1989
    1989 Comment on the article by Tomana et al 1989
    1989 Construction of clinical algorithms for educational programs 1989
    1989 Folic acid treatment in methotrexate‐treated rheumatoid arthritis patients: comment on the article by Furst and Kremer 1989
    1989 Impotence in three rheumatoid arthritis patients treated with methotrexate 1989
    1989 Intraarticular corticosteroid injections: Should we rest the joints? 1989
    1989 Intraarticular corticosteroid injections: Should we rest the joints? 1989
    1989 Involvement of the cervical spine in rheumatoid arthritis 1989
    1989 Methotrexate-induced liver abnormalities in rheumatoid arthritis 1989
    1989 Molecular analysis of HLA‐D region genes in seropositive rheumatoid arthritis 1989
    1989 Physician dropout 1989
    1989 Predicting individual differences in pain and functional impairment among patients with rheumatoid arthritis 1989
    1989 Rheumatoid arthritis in American blacks: A clinical and radiological study 1989
    1989 Septic arthritis due to Mycobacterium phlei presenting as infantile Reiter's syndrome 1989
    1989 Severe reversible interstitial pneumonitis induced by low dose methotrexate 1989
    1989 Spinal stenosis: A comprehensive review of the literature 1989
    1989 The process of training rheumatology research assistants 1989
    1988 Molecular genetic studies of rheumatoid arthritis 1988
    1988 Sexual dysfunction among patients with arthritis 1988
    1988 Articular involvement in human brucellosis. 1988
    1988 Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. 1988
    1988 The use of magnetic resonance imaging (MRI) in patients with rheumatoid arthritis and subluxations of the cervical spine. 1988
    1988 Abnormal glycosylation of serum igg from patients with chronic inflammatory diseases 1988
    1988 Comment on the article by breedveld et al 1988
    1988 Evaluation of patients with back pain of suspected inflammatory nature 1988
    1988 Re: Methotrexate in the treatment of arthritis and connective tissue disease 1988
    1988 The value of the joint alignment and motion scale in rheumatoid arthritis 1988
    1988 Transient osteoporosis of the hip: Magnetic resonance imaging 1988
    1987 Analysis of restriction fragment length polymorphisms in rheumatic diseases 1987
    1987 Brucellar arthritis: A study of 39 Peruvian families 1987
    1987 Scleroderma: DR antigens, autoantibodies and clinical manifestations 1987
    1987 The arthritis of brucellosis: a perspective one hundred years after Bruce's discovery. 1987
    1987 Gouty arthritis of the axial skeleton including the sacroiliac joints. 1987
    1987 Sexual quality-of-life of patients with arthritis compared to arthritis-free controls 1987
    1987 Malnutrition in rheumatoid arthritis 1987
    1987 Toxicity to methotrexate in rheumatoid arthritis 1987
    1987 Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis families 1987
    1987 Toxicity due to remission inducing drugs in RA. 1987
    1987 A new promising treatment in systemic sclerosis: 5-fluorouracil 1987
    1987 Analyses of hla linkage in white families with multiple cases of seropositive rheumatoid arthritis 1987
    1987 Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: A prospective study 1987
    1987 Gouty Arthritis of the Axial Skeleton Including the Sacroiliac Joints 1987
    1986 HLA studies in brucellar spondylitis 1986
    1986 HLA antigens and gold toxicity in American blacks with rheumatoid arthritis 1986
    1986 DR2 positivity and response to methotrexate in rheumatoid arthritis 1986
    1986 Infection versus disease activity in rheumatoid arthritis: Eight years’ experience 1986
    1986 Meeting highlights: Workshop on epidemiology of the rheumatic diseases in the Americas 1986
    1986 Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritis 1986
    1986 Rheumatic manifestations of brucellosis. 1986
    1986 Tissue typing in brucellosis. 1986
    1985 HLA studies in brucellar spondylitis 1985
    1985 Humoral immune abnormalities in human brucellosis. 1985
    1985 Comment on letter by Alarcón et al 1985
    1985 Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial 1985
    1985 DR antigens in systemic sclerosis: lack of clinical correlations 1985
    1985 Double‐blind, multicenter controlled trial comparing topical dimethyl sulfoxide and normal saline for treatment of hand ulcers in patients with systemic sclerosis 1985
    1985 Familial studies in human brucellosis 1985
    1985 HLA‐Bw35 and gold toxicity in rheumatoid arthritis 1985
    1985 In vitro IgM and IgM rheumatoid factor production and response to remittive agents in rheumatoid arthritis 1985
    1985 Paracoccidioides brasiliensis arthritis. Report of a case and review of the literature 1985
    1985 Pure red cell aplasia and protein‐losing enteropathy in a patient with systemic lupus erythematosus 1985
    1985 The carpometacarpal ratio: A useful method for assessing disease progression in rheumatoid arthritis 1985
    1984 In vitro synthesis of IgM and IgM rheumatoid factor in seronegative arthritides 1984
    1984 Azathioprine versus d‐penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold 1984
    1984 Bullous lupus erythematosus rash worsened by dapsone 1984
    1984 Dr Antigens and Gold Toxicity in white rheumatoid arthritis patients 1984
    1983 DR antigen distribution in blacks with rheumatoid arthritis 1983
    1983 CREG antigens differentially influence expression of extraarticular manifestations in whites and blacks with rheumatoid arthritis 1983
    1983 Seronegative rheumatoid arthritis and b7‐creg: disparate results 1983
    1983 Systemic lupus erythematosus, gout, and Paget's disease 1983
    1982 Articular involvement in human Brucellosis: A retrospective analysis of 304 cases 1982
    1982 Differential patterns of in vitro IgM rheumatoid factor synthesis in seronegative and seropositive rheumatoid arthritis 1982
    1982 Seronegative rheumatoid arthritis. 1982
    1981 Reactive arthritis associated with brucellosis: HAL studies 1981

    Book

    Year Title Altmetric
    2008 Chapter 10 Gastrointestinal Manifestations of Rheumatoid Arthritis.  Ed. 8.  2008

    Chapter

    Year Title Altmetric
    2017 Gastrointestinal Manifestations of Rheumatoid Arthritis.  333-348. 2017
    2016 Epidemiology.  15-21. 2016
    2016 Socioeconomic Aspects of Systemic Lupus Erythematosus.  39-42. 2016
    2012 Other novel immunotherapeutic agents in the pipeline and future directions.  81-90. 2012
    2012 Musculoskeletal involvement.  149-155. 2012
    2007 Epidemiology of Systemic Lupus Erythematosus.  1-18. 2007

    Full Name

  • Graciela Alarcon